Advertisement

Topics

Companies Related to "Grey Matter Damage at the Earliest Phase of Multiple Sclerosis : a Longitudinal 7T MRI Study" [Most Relevant Company Matches] RSS

22:36 EST 20th February 2019 | BioPortfolio

Here are the most relevant search results for "Grey Matter Damage at the Earliest Phase of Multiple Sclerosis : a Longitudinal 7T MRI Study" found in our extensive corporate database of over 50,000 company records.

Showing "Grey Matter Damage Earliest Phase Multiple Sclerosis Longitudinal" Companies 1–25 of 2,200+

Extremely Relevant

Familia Unida

Familia Unida living with Multiple Sclerosis (FULWMS) is the first bilingual, English/Spanish Multiple Sclerosis non-profit organization. It serves over thousands of individuals and families affected by Multiple Sclerosis (MS) and other disabilities.


Relevant

MS Central Support

Multiple Sclerosis a life-long chronic disease. Multiple Sclerosis signifies the following: "Multiple" refers to the many areas of inflammation and demyelination that occurs over time. "Sclerosis" means scarring. MS is an autoimmune disease. In MS, the immune system attacks the body's myelin. Myelin is a fatty protein that acts as an insulating matter for nerves. When myelin becomes damaged (demye...

Symbiotix Biotherapies, Inc.

Symbiotix Biotherapies, Inc. is a pioneering microbiome company founded on the basis of over two decades of research at Brigham & Women’s Hospital/Harvard Medical School, California Institute of Technology and Dartmouth College. Symbiotix is developing a novel class of Treg-modulating therapeutics based on molecules derived from the human microbiome. ...


Phase 2 Discovery, Inc.

Phase 2 Discovery (P2D) is a pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) disorders such as insomnia, anxiety, depression, attention disorders and neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).At P2D, we are using our understanding of the treatme...

Grey Wolf Animal Health Inc.

Grey Wolf Animal Health Inc. is a specialty animal health company focused on improving the lives and well-being of vets and pets in Canada and abroad. Founded in 2015 by a veterinarian, Grey Wolf is bringing to market products, solutions and services that meet the underserved needs of veterinarians, pets and clinics across Canada and around the world. Fo...

Jack S. Burks, MD

Jack Burks, MD is a neurologist, researcher, author, and one of the foremost authorities in Multiple Sclerosis who lectures and consults internationally on Multiple Sclerosis research and patient care issues related to Multiple Sclerosis. He holds numerous positions including:) Board Certified Neurologist (American Board of Neurology and Psychiatry) ) Certified in Neurological Rehabilitation (Amer...

Premier Biomedical, Inc.

Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, specifically targeting the treatment of Alzheimer's Disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Blood Sepsis and Viremia, and Cancer. Premier has licensed t...

Eva & Estela Wear Ur Love

Eva & Estela Wear Ur Love is a growing, family-owned t-shirt and apparel business created to raise awareness for multiple sclerosis. Eva & Estela Wear Ur Love is the entrepreneurial endeavor of Kristen Sitarski-Munoz of Williamstown, NJ. Sitarski-Munoz and her husband Ryan faced the simultaneous struggle of job losses and Ryan’s diagnosis of multiple ...

National Multiple Sclerosis Society: Lone Star

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances ...

Premier Biomedical Inc.

Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, in collaboration with the University of Texas at El Paso and US Department of Defense, specifically targeting the treatment of Alzheimer's disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (...

Acorda Therapeutics, Inc.

Acorda Therapeutics is a biotechnology company developing therapies for multiple sclerosis, spinal cord injury and other nervous system disorders. The Company's marketed products include AMPYRA®(dalfampridine) Extended Release Tablets, 10 mg, a potassium channel blocker approved as a treatment to improve walking in patients with multiple sclerosis (MS); this w...

Consortium of Multiple Sclerosis Centers

Multiple Sclerosis Association of America

International Multiple Sclerosis Management Practice

Cambridge NeuroScience Incorporated

Cambridge NeuroScience Incorporated is a biopharmaceutical company engaged in the discovery and development of proprietary pharmaceuticals to prevent or treat severe disorders of, or injuries to, the nervous system. Cambridge NeuroScience is focused in two areas of research and development: (i) ion-channel blockers to prevent or treat brain damage resulting from stroke and other forms of brain isc...

Accelerated Cure Project

Accelerated Cure Project for Multiple Sclerosis, www.acceleratedcure.org, is a national nonprofit organization dedicated to curing Multiple Sclerosis (MS) by determining its causes. Accelerated Cure Project believes this effort can be accelerated by organizing the research process and encouraging collaboration between research organizations and clinicians....

Nuron Biotech, Inc.

Nuron Biotech is developing novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. Its team of industry veterans is committed to advancing products that meet unmet medical needs for patients around the globe. Nuron Biotech’s lead drug candidate, RELONSIV™ (interferon beta-1b), is a new chemical ...

Chromos

Chromos is a biopharmaceutical company with two drug development programs focused on inflammatory diseases and thrombotic disorders. BUSINESS FOCUS Developing biological therapies for the treatment of multiple sclerosis (MS), thrombotic disorders and other inflammatory diseases . PROPRIETARY PRODUCTS Two humanized monoclonal antibodies with novel mechanisms of action. CHR-1103 is being developed i...

Shenzhen Beike Biotechnology Co. Ltd.

Beike Biotechnology ( http://www.beikebiotech.com ) is China's leading biotechnology company. Its scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's unique processing technologies prepare the cells for ...

Darwin Grey Communications

Darwin Grey is a medical education company that provides the knowledge and experience to conceive and implement creative and effective communication solutions. You'll find us as ambitious for your brand as you are. We have expertise in cardiology, CNS, dermatology, endocrinology, haematology, HIV/Aids, immunology, infectious disease, medical devices and oncology. From our headquarters just outside...

Elan Corporation, plc

Elan Corporation, plc is a neuroscience-based biotechnology company focused on discovering and developing advanced therapies in neurodegeneration and autoimmune diseases, and realizing the potential of its scientific discoveries to benefit patients and shareholders. The company has two business units: BioNeurology, focused on Alzheimer’s and Parkinson...

ADA Medical Ltd.

ADA Medical Ltd. is a Research Partnership Group of research professionals dedicated to the successful implementation and completion of clinical research projects for the pharmaceutical, biotechnology and medical device industries. We specialize in trial management and support for hospital based as well as outpatient Phase IIb through Phase IV clinical tri...

Mymetics Corporation

Mymetics' primary objective is to develop vaccines and therapies to prevent and treat the effects of certain retroviruses and other infectious diseases, including the human immunodeficiency virus, or HIV, the virus that leads to acquired immunodeficiency syndrome, or AIDS. Mymetics has also recently acquired from a close scientific partner an advanced malaria vaccine project currently in phase...

GREY GOOSE(R) Vodka

grey healthcare group


More From BioPortfolio on "Grey Matter Damage at the Earliest Phase of Multiple Sclerosis : a Longitudinal 7T MRI Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks